Flerie Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
5
- Investments
-
63
- Portfolio
-
30
- Exits
-
9
Flerie General Information
Company Description
Founded in 2011, Flerie is a venture capital investment firm based in Stockholm, Sweden. The firm seeks to invest in early-stage companies in the healthcare sector across Europe, the United States, the United Kingdom, and Israel.
Business Details
Website
www.flerie.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- Skeppsbron 16
- 111 30 Stockholm
- Sweden
Flerie Investments & Acquisitions (63)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Microbiotica | 16-Oct-2026 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 | ||
| AnaCardio | 29-Sep-2026 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Biosergen | 26-Jun-2026 | Drug Discovery | Generating Revenue | |||
| Bonsai Biotherapeutics | 01-Apr-2026 | Biotechnology | Generating Revenue | |||
| Lipum | 20-Mar-2026 | Drug Discovery | Generating Revenue | |||
| Geneos Therapeutics | 10-Mar-2026 | Drug Discovery | Generating Revenue | |||
| Prokarium | 02-Dec-2025 | Drug Discovery | Clinical Trials - Phase 1 | |||
| KAHR Bio | 01-Sep-2025 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Toleranzia | 19-Aug-2025 | Buyout/LBO | Drug Discovery | Generating Revenue | ||
| Nanologica | 25-Apr-2025 | PIPE | Other Pharmaceuticals and Biotechnology | Generating Revenue |
Flerie Exits (9)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Buzzard Pharmaceuticals | 22-Nov-2025 | Out of Business | |
| A3P Biomedical | 06-Mar-2025 | ||
| Provell Pharmaceuticals | 01-Mar-2025 | ||
| XNK Therapeutics | 09-Apr-2024 | ||
| QuTEM | 20-Nov-2023 | ||
| Cobra Biologics | 21-Jan-2020 | ||
| Cormorant Pharmaceuticals | 05-Jul-2016 | Merger/Acquisition | |
| Wilson Therapeutics | 25-May-2016 | IPO |
Flerie Investments by Industry, Year, and Region
Flerie Co-Investors (58)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Ben Franklin Technology Partners of Southeastern Pennsylvania | 1 |
|
|
||
| IP Group |
|
|
|||
| Industrifonden |
|
|
|||
| Khosla Ventures |
|
|
|||
| Kohlberg Kravis Roberts |
|
|
Flerie Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Empros Pharma | Solna, Sweden | 2013 | |
| Xintela | Lund, Sweden | 2009 |
Flerie FAQs
-
What is Flerie?
Founded in 2011, Flerie is a venture capital investment firm based in Stockholm, Sweden.
-
When was Flerie founded?
Flerie was founded in 2011.
-
Where is Flerie headquartered?
Flerie is headquartered in Stockholm, Sweden.
-
What is Flerie's total asset value?
Flerie has around in total assets under management.
-
How many investments has Flerie made?
Flerie has made 63 investments.
-
What has Flerie invested in?
Flerie has made numerous investments in companies like Microbiotica, AnaCardio, and Biosergen within the Drug Discovery industry.
-
What has Flerie invested in recently?
Flerie's latest investment was on 16-Oct-2026 in Microbiotica, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process